Boston, MA (PRWEB) September 20, 2022 Outside of the world of laboratory science, one of the most significant group of contributors to the excellence of
Boston (PRWEB) February 22, 2022 In late 2021, Springer Publishers released the first foundational scientific book in the new field of stem cell science
Asymmetrex Will Discuss the Impact of Its Technology for Dosing Therapeutic Stem Cells
Share Article
During the coming months of May and June, stem cell biotechnology company Asymmetrex is invited to give presentations in several different virtual conferences that span the fields of clinical trial supply, cell biotherapeutics, stem cell science, and stem cell medicine. The company’s relevance to these diverse disciplines reflects the broad scope of the impact of its emerging technologies for determining the dosage of therapeutic stem cells.
Asymmetrex President & CEO
James L. Sherley, M.D., Ph.D.
It’s basic medicine. Finally knowing the stem cell dosage of stem cell treatments must necessarily be better for patients.